TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration.

Iris Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.